Jay Olson
Stock Analyst at Oppenheimer
(4.88)
# 327
Out of 5,096 analysts
1186
Total ratings
47.6%
Success rate
23.2%
Average return
Main Sectors:
Stocks Rated by Jay Olson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NBIX Neurocrine Biosciences | Maintained: Buy | $230 | $145.35 | +58.24% | 91 | Nov 3, 2026 | |
| RTSN Retension Pharmaceuticals | Initiated: Buy | $50 | $11.30 | +342.48% | 1 | Nov 3, 2026 | |
| INCY Incyte | Upgraded: Buy | $120 → $144 | $120.04 | +19.96% | 85 | Oct 29, 2026 | |
| VKTX Viking Therapeutics | Reiterated: Buy | $120 | $26.83 | +347.26% | 41 | Oct 29, 2026 | |
| AMGN Amgen | Rated: Buy | $450 → $480 | $465.45 | +3.13% | 85 | Oct 23, 2026 | |
| SGMT Sagimet Biosciences | Reiterated: Buy | $33 → $38 | $9.69 | +292.16% | 9 | Oct 1, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $60 → $75 | $32.47 | +130.98% | 8 | Sep 14, 2026 | |
| ANL Adlai Nortye Group | Reiterated: Buy | $32 | $9.37 | +241.52% | 2 | Aug 27, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $230 → $260 | $188.17 | +38.17% | 26 | Aug 27, 2026 | |
| BIIB Biogen | Rated: Hold | n/a | $249.01 | - | 100 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $650 | $273.99 | +137.23% | 7 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $4.46 | +684.75% | 2 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.491 | +918.33% | 2 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23.76 | $9.37 | +153.54% | 2 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $5.80 | +762.07% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.7494 | +1,234.40% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $8.71 | +359.24% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $19.23 | +212.01% | 2 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.89 | - | 2 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.32 | - | 15 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $553.15 | - | 8 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $8.41 | +137.81% | 4 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $1.85 | +386.49% | 1 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $40 | $18.86 | +112.09% | 17 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.8053 | +1,141.77% | 6 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 → $140 | $36.95 | +278.89% | 25 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $87.53 | - | 3 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $70.13 | - | 35 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.32 | - | 3 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 → $72 | $37.91 | +89.92% | 2 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $220.83 | - | 5 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 → $36 | $3.62 | +894.48% | 31 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $3.49 | +759.60% | 11 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $650 | $431.16 | +50.76% | 50 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.7999 | +650.09% | 4 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.39 | +192.89% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $27 | $11.66 | +131.56% | 26 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $41.24 | n/a | 14 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.13 | n/a | 5 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $1.78 | n/a | 20 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $0.508 | n/a | 18 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.29 | n/a | 67 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $9.11 | n/a | 6 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $170.33 | n/a | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 | $10.43 | n/a | 35 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 | $20.47 | n/a | 36 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $49.99 | n/a | 24 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.57 | n/a | 19 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.7096 | n/a | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $10 | $21.60 | n/a | 6 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.37 | n/a | 10 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.85 | n/a | 16 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $3.84 | n/a | 9 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.79 | n/a | 10 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.472 | n/a | 6 | Jun 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $9 | $1.81 | n/a | 45 | Aug 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $7 | $13.50 | n/a | 27 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.50 | n/a | 20 | Jul 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.04 | n/a | 19 | Mar 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.1675 | n/a | 6 | Mar 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.41 | n/a | 9 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.49 | n/a | 8 | Jan 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.15 | n/a | 5 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 → $0.25 | $3.65 | n/a | 5 | Mar 30, 2016 |
Neurocrine Biosciences
Nov 3, 2026
Maintained: Buy
Price Target: $230
Current: $145.35
Upside: +58.24%
Retension Pharmaceuticals
Nov 3, 2026
Initiated: Buy
Price Target: $50
Current: $11.30
Upside: +342.48%
Incyte
Oct 29, 2026
Upgraded: Buy
Price Target: $120 → $144
Current: $120.04
Upside: +19.96%
Viking Therapeutics
Oct 29, 2026
Reiterated: Buy
Price Target: $120
Current: $26.83
Upside: +347.26%
Amgen
Oct 23, 2026
Rated: Buy
Price Target: $450 → $480
Current: $465.45
Upside: +3.13%
Sagimet Biosciences
Oct 1, 2026
Reiterated: Buy
Price Target: $33 → $38
Current: $9.69
Upside: +292.16%
Definium Therapeutics
Sep 14, 2026
Reiterated: Buy
Price Target: $60 → $75
Current: $32.47
Upside: +130.98%
Adlai Nortye Group
Aug 27, 2026
Reiterated: Buy
Price Target: $32
Current: $9.37
Upside: +241.52%
Revolution Medicines
Aug 27, 2026
Reiterated: Buy
Price Target: $230 → $260
Current: $188.17
Upside: +38.17%
Biogen
Aug 17, 2026
Rated: Hold
Price Target: n/a
Current: $249.01
Upside: -
Aug 17, 2026
Reiterated: Buy
Price Target: $650
Current: $273.99
Upside: +137.23%
Aug 14, 2026
Reiterated: Buy
Price Target: $35
Current: $4.46
Upside: +684.75%
Aug 13, 2026
Reiterated: Buy
Price Target: $5
Current: $0.491
Upside: +918.33%
Aug 12, 2026
Reiterated: Buy
Price Target: $23.76
Current: $9.37
Upside: +153.54%
Aug 6, 2026
Reiterated: Buy
Price Target: $50
Current: $5.80
Upside: +762.07%
Aug 6, 2026
Reiterated: Buy
Price Target: $10
Current: $0.7494
Upside: +1,234.40%
Aug 6, 2026
Reiterated: Buy
Price Target: $40
Current: $8.71
Upside: +359.24%
Aug 5, 2026
Reiterated: Buy
Price Target: $60
Current: $19.23
Upside: +212.01%
Jul 20, 2026
Rated: Hold
Price Target: n/a
Current: $1.89
Upside: -
Jul 20, 2026
Rated: Hold
Price Target: n/a
Current: $1.32
Upside: -
Jul 20, 2026
Rated: Hold
Price Target: n/a
Current: $553.15
Upside: -
Jul 7, 2026
Reiterated: Buy
Price Target: $20
Current: $8.41
Upside: +137.81%
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $1.85
Upside: +386.49%
May 11, 2026
Reiterated: Buy
Price Target: $35 → $40
Current: $18.86
Upside: +112.09%
May 11, 2026
Reiterated: Buy
Price Target: $10
Current: $0.8053
Upside: +1,141.77%
May 8, 2026
Reiterated: Buy
Price Target: $115 → $140
Current: $36.95
Upside: +278.89%
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $87.53
Upside: -
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $70.13
Upside: -
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $3.32
Upside: -
Apr 22, 2026
Reiterated: Buy
Price Target: $61 → $72
Current: $37.91
Upside: +89.92%
Apr 20, 2026
Rated: Hold
Price Target: n/a
Current: $220.83
Upside: -
Mar 18, 2026
Reiterated: Buy
Price Target: $44 → $36
Current: $3.62
Upside: +894.48%
Mar 9, 2026
Reiterated: Buy
Price Target: $30
Current: $3.49
Upside: +759.60%
Feb 9, 2026
Reiterated: Buy
Price Target: $650
Current: $431.16
Upside: +50.76%
Nov 13, 2025
Reiterated: Buy
Price Target: $6
Current: $0.7999
Upside: +650.09%
Nov 13, 2025
Reiterated: Buy
Price Target: $7
Current: $2.39
Upside: +192.89%
Nov 7, 2025
Reiterated: Buy
Price Target: $40 → $27
Current: $11.66
Upside: +131.56%
Oct 27, 2025
Reiterated: Buy
Price Target: $90
Current: $41.24
Upside: n/a
Oct 7, 2025
Reiterated: Buy
Price Target: $8
Current: $1.13
Upside: n/a
Oct 2, 2025
Reiterated: Buy
Price Target: $18
Current: $1.78
Upside: n/a
Jun 16, 2025
Reiterated: Buy
Price Target: $65
Current: $0.508
Upside: n/a
Jun 16, 2025
Reiterated: Hold
Price Target: n/a
Current: $8.29
Upside: n/a
Mar 14, 2025
Downgraded: Hold
Price Target: n/a
Current: $9.11
Upside: n/a
Feb 12, 2025
Reiterated: Buy
Price Target: $115
Current: $170.33
Upside: n/a
Dec 10, 2024
Reiterated: Hold
Price Target: $14
Current: $10.43
Upside: n/a
Nov 8, 2024
Reiterated: Hold
Price Target: $17
Current: $20.47
Upside: n/a
Nov 6, 2024
Reiterated: Buy
Price Target: $95
Current: $49.99
Upside: n/a
Nov 5, 2024
Reiterated: Hold
Price Target: n/a
Current: $2.57
Upside: n/a
Nov 4, 2024
Reiterated: Buy
Price Target: $9
Current: $0.7096
Upside: n/a
Oct 17, 2024
Reiterated: Buy
Price Target: $9 → $10
Current: $21.60
Upside: n/a
Feb 26, 2024
Rated: Hold
Price Target: n/a
Current: $1.37
Upside: n/a
Feb 14, 2023
Downgraded: Hold
Price Target: n/a
Current: $15.85
Upside: n/a
Nov 14, 2022
Upgraded: Buy
Price Target: $7
Current: $3.84
Upside: n/a
Aug 14, 2020
Rated: Hold
Price Target: n/a
Current: $9.79
Upside: n/a
Jun 12, 2020
Rated: Hold
Price Target: n/a
Current: $0.472
Upside: n/a
Aug 22, 2019
Reiterated: Buy
Price Target: $10 → $9
Current: $1.81
Upside: n/a
Aug 14, 2019
Reiterated: Buy
Price Target: $15 → $7
Current: $13.50
Upside: n/a
Jul 22, 2019
Downgraded: Hold
Price Target: n/a
Current: $3.50
Upside: n/a
Mar 24, 2019
Reiterated: Buy
Price Target: n/a
Current: $1.04
Upside: n/a
Mar 15, 2019
Rated: Hold
Price Target: n/a
Current: $0.1675
Upside: n/a
Dec 8, 2017
Rated: Hold
Price Target: n/a
Current: $2.41
Upside: n/a
Jan 20, 2017
Rated: Hold
Price Target: n/a
Current: $9.49
Upside: n/a
Dec 30, 2016
Reiterated: Hold
Price Target: n/a
Current: $5.15
Upside: n/a
Mar 30, 2016
Reiterated: Sell
Price Target: $2 → $0.25
Current: $3.65
Upside: n/a